A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2025

Conditions
Migraine
Interventions
DRUG

MEDI0618

MEDI0618 per protocol

DRUG

Placebo

Volume-matched placebo for all arms

Trial Locations (54)

1036

Research Site, Budapest

1138

Research Site, Budapest

2400

Research Site, Dunaújváros

2600

Research Site, Glostrup Municipality

10001

Research Site, New York

10117

Research Site, Berlin

20132

Research Site, Milan

25827

Research Site, Crab Orchard

27100

Research Site, Pavia

27201

Research Site, Kladno

28046

Research Site, Madrid

29486

Research Site, Summerville

32746

Research Site, Lake Mary

33033

Research Site, Homestead

33135

Research Site, Miami

33615

Research Site, Tampa

33705

Research Site, St. Petersburg

35205

Research Site, Birmingham

35801

Research Site, Huntsville

40207

Research Site, Louisville

45147

Research Site, Essen

46010

Research Site, Valencia

46026

Research Site, Valencia

51601

Research Site, Rychnov nad Kněžnou

53092

Research Site, Mequon

65929

Research Site, Frankfurt am Main

78731

Research Site, Austin

80539

Research Site, Munich

90048

Research Site, Los Angeles

92011

Research Site, Carlsbad

02818

Research Site, East Greenwich

100 00

Research Site, Prague

120 00

Research Site, Prague

150 00

Research Site, Prague

160 00

Research Site, Prague

186 00

Research Site, Prague

09111

Research Site, Chemnitz

01307

Research Site, Dresden

00128

Research Site, Roma

00163

Research Site, Roma

2333 ZA

Research Site, Leiden

85-796

Research Site, Bydgoszcz

40-081

Research Site, Katowice

30-539

Research Site, Krakow

31-501

Research Site, Krakow

20-701

Research Site, Lublin

60-529

Research Site, Poznan

61-485

Research Site, Poznan

00-215

Research Site, Warsaw

02-172

Research Site, Warsaw

02-677

Research Site, Warsaw

06080

Research Site, Badajoz

08003

Research Site, Barcelona

08035

Research Site, Barcelona

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

AbbVie

INDUSTRY